-
Mashup Score: 0Study Compares Blast Reduction Strategies in Accelerated, Blast Phase MPN | Blood Cancers Today - 21 day(s) ago
The primary endpoint was overall best response after blast-reduction therapy.
Source: bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13D Model Suggests Role for Interferon Alfa | Blood Cancers Today - 2 month(s) ago
A 3D model used to analyze the effects of IFNa in the bone marrow microenvironment could help in understanding fibrotic progression in JAK2V617F mutation–positive MPNs.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7
Join us to watch leading MPN experts present summaries on the most significant abstracts from ASH 2023 followed by interactive panel discussions debating current clinical issues. Chaired by Dr. Claire Harrison, with co-moderators Drs. Adam Mead, Francesca Palandri Webinar attendees will be given the opportunity to send in their questions where they will be answered during the live panel…
Source: comsync.lijit.comCategories: General Medicine News, Onc News and JournalsTweet-
The Post-ASH 2023 #MPN Highlights takes place in 90 mins🚨 📷 Ft. presentations & discussions with leading experts @harrisoncn1 @AdamMead_Oxford @mpdrc @doctorpemm @sk_tantravahi @Vikas_Gupta_1 & more! Last chance to register: https://t.co/eSMcc98n8g Covering key trials inc.… https://t.co/WZx2egtowI https://t.co/jQV009qVAc
-
-
Mashup Score: 1
Join us to watch leading MPN experts present summaries on the most significant abstracts from ASH 2023 followed by interactive panel discussions debating current clinical issues. Chaired by Dr. Claire Harrison, with co-moderators Drs. Adam Mead, Francesca Palandri Webinar attendees will be given the opportunity to send in their questions where they will be answered during the live panel…
Source: comsync.lijit.comCategories: General Medicine News, Onc News and JournalsTweet-
The Post-ASH 2023 #MPN Highlights takes place today🚨 📷 Covering key trials inc. TRANSFORM-1, MANIFEST-2, FREEDOM2, XPORT-MF-034, SIMPLIFY-1, MOMENTUM, DALIAH, IMG-7289-CTP-201, ACE-536-MF-001 REGISTER NOW 📷 https://t.co/eSMcc98n8g Chaired by @harrisoncn1 & co-moderated by… https://t.co/bgFvYHceB4 https://t.co/W6FjCyZJRw
-
-
Mashup Score: 0European Commission Approves Momelotinib for Myelofibrosis/Anemia - 3 month(s) ago
Results from the phase 3 MOMENTUM trial led momelotinib to being approved by the European Commission for patients with myelofibrosis plus anemia and splenomegaly.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0CHMP Shares Positive Opinion of Momelotinib for Myelofibrosis/Anemia - 5 month(s) ago
If momelotinib receives approval in the European Union, it will become the only agent for the treatment of myelofibrosis coupled with moderate to severe anemia.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0SUMMARY - OncLive/State of the Science Summit/Leukemia/Lymphoma/Chicago/October 23, 2023 - 7 month(s) ago
OncLive® State of the Science Summit: Disease State, Month Day, Year. Oncology live event features research and clinical advances in oncology.
Source: event.onclive.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Symptom Assessments, Guidelines Inform Nurses Whether They Are ‘Moving in the Right Direction’ in MPN Treatment - 8 month(s) ago
Tetyana Furmanets, CRNP, MSN, discusses the tools she uses to help patients navigate myeloproliferative neoplasm symptom management.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Symptom Assessments, Guidelines Inform Nurses Whether They Are ‘Moving in the Right Direction’ in MPN Treatment - 8 month(s) ago
Tetyana Furmanets, CRNP, MSN, discusses the tools she uses to help patients navigate myeloproliferative neoplasm symptom management.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Symptom Assessments, Guidelines Inform Nurses Whether They Are ‘Moving in the Right Direction’ in MPN Treatment - 8 month(s) ago
Tetyana Furmanets, CRNP, MSN, discusses the tools she uses to help patients navigate myeloproliferative neoplasm symptom management.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
HSCT after blast reduction therapy improved survival benefit in patients with accelerated and blast phase myeloproliferative neoplasms. #MPN The study was led by Marta Davidson, MD, of @pmcancercentre, and published in @BloodAdvances. Read more: https://t.co/mTL80NyhGC https://t.co/owI6dJeipw